Absence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Activity in Prepandemic Sera From Individuals With Recent Seasonal Coronavirus Infection.
COVID-19
SARS-CoV-2
antibodies
neutralization
seasonal coronavirus
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
07 09 2021
07 09 2021
Historique:
received:
08
10
2020
accepted:
01
12
2020
pubmed:
4
12
2020
medline:
4
12
2020
entrez:
3
12
2020
Statut:
ppublish
Résumé
Cross-reactive immune responses elicited by seasonal coronaviruses might affect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) susceptibility and disease outcomes. We measured neutralizing activity against SARS-CoV-2 in prepandemic sera from patients with prior polymerase chain reaction scan-confirmed seasonal coronavirus infection. Although neutralizing activity against seasonal coronaviruses was detected in nearly all sera, cross-reactive neutralizing activity against SARS-CoV-2 was undetectable.
Identifiants
pubmed: 33270134
pii: 6017810
doi: 10.1093/cid/ciaa1803
pmc: PMC7799301
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1208-e1211Subventions
Organisme : NIAID NIH HHS
ID : R01 AI078788
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : R37AI640003
Organisme : NIAID NIH HHS
ID : F30 AI157898
Pays : United States
Organisme : NIH HHS
ID : T32GM007739
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007739
Pays : United States
Commentaires et corrections
Type : UpdateOf
Type : CommentIn
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Références
Nature. 2020 Aug;584(7821):437-442
pubmed: 32555388
Science. 2020 Dec 11;370(6522):1339-1343
pubmed: 33159009
J Exp Med. 2020 Nov 2;217(11):
pubmed: 32692348
J Clin Microbiol. 2010 Aug;48(8):2940-7
pubmed: 20554810
Science. 2020 Aug 7;369(6504):731-736
pubmed: 32540900
Nat Med. 2020 Nov;26(11):1691-1693
pubmed: 32929268
Science. 2020 Nov 27;370(6520):
pubmed: 32994364
Nature. 2020 Nov;587(7833):270-274
pubmed: 32726801
Trends Microbiol. 2016 Jun;24(6):490-502
pubmed: 27012512
Am J Med. 2015 Nov;128(11):1251.e11-20
pubmed: 26087047
J Clin Virol. 2012 Feb;53(2):135-9
pubmed: 22188723
Nat Commun. 2021 May 19;12(1):2938
pubmed: 34011939